TATA Health International Holdings (HKSE:01255) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01255 TATA Health International Holdings Ltd HKSE:01255
22 GF Score
Price HK$2.18
GF Value HK$0.22
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is TATA Health International Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

TATA Health International Holdings Valuation Rank Related Terms

HKSE:01255
22GF Score
TATA Health International Holdings Ltd HKSE:01255
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?

Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued. The current stock price of HK$2.18 is trading 890.9% above its estimated GF Value™ of HK$0.22. GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:01255:

  • Valuation Rank:
  • GF Value™: HK$0.22 vs. price of HK$2.18 (890.9% above fair value)
  • GF Score™: 22/100 with 8 warning signs

No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TATA Health International Holdings Business Description

Address 15-33 Kwai Tak Street, Block 2, Flat F-J, 11th Floor, Kwai Tak Industrial Centre, Kwai Chung, New Territories, Hong Kong, HKG
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score

Get the complete analysis for HKSE:01255

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.18
Price
HK$0.22
GF Value